{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:01:56Z","timestamp":1772028116245,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.bbadis.2013.05.026","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T02:03:59Z","timestamp":1370484239000},"page":"1906-1909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)"],"prefix":"10.1016","volume":"1832","author":[{"given":"Jacqueline A.","family":"Hawkins-Salsbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Sands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbadis.2013.05.026_bb0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nbd.2004.02.010","article-title":"Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Bible","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0010","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","article-title":"Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"15","author":"Cabrera-Salazar","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0020","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/hmg\/11.12.1421","article-title":"An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease","volume":"11","author":"Chattopadhyay","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2013.05.026_bb0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1399-0004.1990.tb04188.x","article-title":"Batten's disease: failure of allogeneic bone marrow transplantation to arrest disease progression in a canine model","volume":"37","author":"Deeg","year":"1990","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0030","doi-asserted-by":"crossref","first-page":"ra89","DOI":"10.1126\/scitranslmed.3001380","article-title":"Replacing the enzyme \u03b1-l-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I","volume":"2","author":"Dierenfeld","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2008.10.021","article-title":"Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-pick a disease","volume":"215","author":"Dodge","year":"2009","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.026_bb0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2350\/07-03-0242.1","article-title":"A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera","volume":"11","author":"Galvin","year":"2008","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0045","author":"Gavin","year":"2013"},{"issue":"2","key":"10.1016\/j.bbadis.2013.05.026_bb0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","article-title":"Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Griffey","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.026_bb0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","article-title":"AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis","volume":"12","author":"Griffey","year":"2005","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.026_bb0060","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","article-title":"CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"13","author":"Griffey","year":"2006","journal-title":"Mol. Ther."},{"issue":"24","key":"10.1016\/j.bbadis.2013.05.026_bb0065","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.251485198","article-title":"Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice","volume":"98","author":"Gupta","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbadis.2013.05.026_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00697751","article-title":"Infantile type of so-called neuronal ceroid-lipofuscinosis. Histological and electron microscopic studies","volume":"26","author":"Haltia","year":"1973","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.026_bb0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-510X(73)90076-2","article-title":"Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies","volume":"18","author":"Haltia","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0080","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1460-9568.2009.06666.x","article-title":"Examination of intravenous and intra-CSF injection protein delivery for treatment of neurologic disease","volume":"29","author":"Hemsley","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2013.05.026_bb0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2012.05.009","article-title":"Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis","volume":"107","author":"Hu","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nbd.2004.08.013","article-title":"Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons","volume":"18","author":"Jalanko","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.bbadis.2013.05.026_bb0095","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/hmg\/ddl078","article-title":"Palmitoyl-protein thioesterase-1 deficiency leads to the activation of caspase-9 and contributes to rapid neurodegeneration in INCL","volume":"15","author":"Kim","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.bi.61.070192.001515","article-title":"Structure and function of the mannose 6-phosphate\/insulinlike growth factor II receptors","volume":"61","author":"Kornfeld","year":"1992","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.bbadis.2013.05.026_bb0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-973677","article-title":"Bone marrow transplantation in late infantile Batten disease and juvenile Batten disease","volume":"28","author":"Lake","year":"1997","journal-title":"Neuropediatrics"},{"issue":"8","key":"10.1016\/j.bbadis.2013.05.026_bb0110","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/WNL.57.8.1411","article-title":"Hematopoietic stem cell transplantation in infantile neuronal ceroid lipofuscinosis","volume":"57","author":"Lonnqvist","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.05.026_bb0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.20444","article-title":"Convection infusion of glucocerebrosidase for neuronopathic Gaucher's disease","volume":"57","author":"Lonser","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbadis.2013.05.026_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10545-006-0225-z","article-title":"Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis","volume":"29","author":"Lu","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2013.05.026_bb0125","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ymgme.2009.12.002","article-title":"Human recombinant palmitoyl-protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis","volume":"99","author":"Lu","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"19","key":"10.1016\/j.bbadis.2013.05.026_bb0130","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1073\/pnas.93.19.10046","article-title":"Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase","volume":"93","author":"Lu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbadis.2013.05.026_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1388-1981(02)00158-0","article-title":"The effects of lysosomotropic agents on normal and INCL cells provide further evidence for the lysosomal nature of palmitoyl-protein thioesterase function","volume":"1583","author":"Lu","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.05.026_bb0140","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.expneurol.2009.03.040","article-title":"Promising CNS-directed enzyme replacement for lysosomal storage diseases","volume":"218","author":"Macauley","year":"2009","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.bbadis.2013.05.026_bb0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.23545","article-title":"Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis","volume":"71","author":"Macauley","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0150","doi-asserted-by":"crossref","first-page":"e40509","DOI":"10.1371\/journal.pone.0040509","article-title":"Systemic administration of tripeptidyl peptidase 1 in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification","volume":"7","author":"Meng","year":"2012","journal-title":"PLoS One"},{"issue":"941","key":"10.1016\/j.bbadis.2013.05.026_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1126\/science.169.3941.141","article-title":"Inborn errors of mucopolysaccharide metabolism","volume":"169","author":"Neufeld","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.05.026_bb0160","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1523\/JNEUROSCI.2676-05.2006","article-title":"Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis","volume":"26","author":"Passini","year":"2006","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.026_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0959-437X(00)00086-1","article-title":"Genetics of the neuronal ceroid lipofuscinoses","volume":"10","author":"Peltonen","year":"2000","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"5","key":"10.1016\/j.bbadis.2013.05.026_bb0170","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10545-011-9446-x","article-title":"Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis","volume":"35","author":"Roberts","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"10","key":"10.1016\/j.bbadis.2013.05.026_bb0175","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/hmg\/dds038","article-title":"The blood\u2013brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol","volume":"21","author":"Saha","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.026_bb0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-510X(73)90075-0","article-title":"Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients","volume":"18","author":"Santavuori","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","article-title":"Immunosuppression alters disease severity in juvenile Batten disease mice","volume":"230","author":"Seehafer","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.bbadis.2013.05.026_bb0190","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jnr.10412","article-title":"Engraftment of sorted\/expanded human central nervous system stem cells from fetal brain","volume":"69","author":"Tamaki","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.026_bb0195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.stem.2009.05.022","article-title":"Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"5","author":"Tamaki","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"26","key":"10.1016\/j.bbadis.2013.05.026_bb0200","doi-asserted-by":"crossref","first-page":"14720","DOI":"10.1073\/pnas.97.26.14720","article-title":"Direct isolation of human central nervous system stem cells","volume":"97","author":"Uchida","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"26","key":"10.1016\/j.bbadis.2013.05.026_bb0205","doi-asserted-by":"crossref","first-page":"15831","DOI":"10.1074\/jbc.271.26.15831","article-title":"Lysosomal targeting of palmitoyl-protein thioesterase","volume":"271","author":"Verkruyse","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6541","key":"10.1016\/j.bbadis.2013.05.026_bb0210","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/376584a0","article-title":"Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis","volume":"376","author":"Vesa","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.05.026_bb0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","article-title":"Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"104","author":"Vuillemenot","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.bbadis.2013.05.026_bb0220","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/hmg\/ddm324","article-title":"ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones","volume":"17","author":"Wei","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.bbadis.2013.05.026_bb0225","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/hmg\/ddq555","article-title":"Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol","volume":"20","author":"Wei","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2013.05.026_bb0235","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ajmg.1320420429","article-title":"Altered protein patterns in brains of children with neuronal ceroid lipofuscinosis","volume":"42","author":"Wisniewski","year":"1992","journal-title":"Am. J. Med. Genet."},{"issue":"49","key":"10.1016\/j.bbadis.2013.05.026_bb0240","doi-asserted-by":"crossref","first-page":"35765","DOI":"10.1074\/jbc.M705124200","article-title":"Lysosomal dysfunction results in altered energy balance","volume":"282","author":"Woloszynek","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbadis.2013.05.026_bb0250","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/mt.2011.130","article-title":"Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Xu","year":"2011","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2013.05.026_bb0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2011.09.019","article-title":"Protective potential of resveratrol against oxidative stress and apoptosis in Batten disease lymphoblast cells","volume":"414","author":"Yoon","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bbadis.2013.05.026_bb0260","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/86554","article-title":"Lysosomal ceroid depletion by drugs: therapeutic implications for a hereditary neurodegenerative disease of childhood","volume":"7","author":"Zhang","year":"2001","journal-title":"Nat. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T09:22:35Z","timestamp":1539595355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913001889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0925443913001889"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.026","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}